NON vitamin-K oral anticoagulants (NOACs) apixaban and rivaroxaban now have a reversal agent or antidote for use when reversal is needed due to uncontrolled bleeding.
The EMA is considering conditional approval - see ema.europa.eu.
THE Pharmacy Guild of Australia has raised concerns over Echo Therapeutics’ decision to limit distribution of Pegasys (Peginteferon Alfa-2A) injections exclusively through Echo’s home delivery partner, JustMeds, citing the approach as a disruption to patient choice and National Medicines Policy principles.
DR JARED Miles, a Yuwi man and lecturer in the University of Queensland’s (UQ) School of Pharmacy, is addressing the significant underrepresentation of Indigenous people in Australia’s pharmacy workforce.
THE 2024 Liptember campaign, in partnership with Chemist Warehouse Group, has raised $2.1 million for women’s mental health, marking 15 years of the annual initiative.